Related references
Note: Only part of the references are listed.Intact blood-brain barrier during spontaneous attacks of migraine without aura: a 3T DCE-MRI study
F. M. Amin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Possible Involvement of the CACNA1E Gene in Migraine: A Search for Single Nucleotide Polymorphism in Different Clinical Phenotypes
Anna Ambrosini et al.
HEADACHE (2017)
PACAP38: Emerging Drug Target in Migraine and Cluster Headache
Anne Luise Haulund Vollesen et al.
HEADACHE (2017)
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines
Joshua M. Cohen et al.
HEADACHE (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Sex differences in the epidemiology, clinical features, and CrossMark pathophysiology of migraine
Kjersti Grotta Vetvik et al.
LANCET NEUROLOGY (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
Erenumab (AMG 334) in episodic migraine Interim analysis of an ongoing open-label study
Messoud Ashina et al.
NEUROLOGY (2017)
Fremanezumab for the Preventive Treatment of Chronic Migraine
Stephen D. Silberstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention
Jennifer Y. Xie et al.
CEPHALALGIA (2017)
Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura
Anders Hougaard et al.
BRAIN (2017)
Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study
Rezvan Noruzzadeh et al.
HEADACHE (2016)
Bench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients
Peter J. Goadsby
BRAIN (2016)
Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine
Anna P. Andreou et al.
BRAIN (2016)
Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine
Christoph J. Schankin et al.
BRAIN (2016)
The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks
Laura H. Schulte et al.
BRAIN (2016)
Oxytocin receptor: Expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders
Alexander Tzabazis et al.
CEPHALALGIA (2016)
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Tiffini Voss et al.
CEPHALALGIA (2016)
Migraine: What Imaging Reveals
Catherine D. Chong et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine
Eva Cernuda-Morollon et al.
HEADACHE (2016)
Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography
Eva Johansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Genetic insights into migraine and glutamate: a protagonist driving the headache
Claudia F. Gasparini et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
Marcelo E. Bigal et al.
NEUROLOGY (2016)
The migraine postdrome An electronic diary study
Nicola J. Giffin et al.
NEUROLOGY (2016)
IMMUNOHISTOCHEMICAL LOCALIZATION OF THE CALCITONIN GENE-RELATED PEPTIDE BINDING SITE IN THE PRIMATE TRIGEMINOVASCULAR SYSTEM USING FUNCTIONAL ANTAGONIST ANTIBODIES
Silke Miller et al.
NEUROSCIENCE (2016)
Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
Song Guo et al.
PAIN (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine
Yuen H. Kwok et al.
JOURNAL OF PAIN RESEARCH (2016)
Metabotropic glutamate receptor 5: a target for migraine therapy
Maggie W. Waung et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
New players in the preventive treatment of migraine
Dimos D. Mitsikostas et al.
BMC MEDICINE (2015)
CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
Lars Edvinsson
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons
P. Pozo-Rosich et al.
CEPHALALGIA (2015)
Evaluation of the impact of neutralizing antibodies on IFNβ response
Antonio Bertolotto
CLINICA CHIMICA ACTA (2015)
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
B. Rup et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
CGRP Mechanism Antagonists and Migraine Management
Nazia Karsan et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2015)
Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety
Jacinta L. Johnson et al.
HEADACHE (2015)
Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know
Stephen Silberstein et al.
HEADACHE (2015)
The Journey to Establish CGRP as a Migraine Target: A Retrospective View
Lars Edvinsson
HEADACHE (2015)
Critical evaluation of three hemodynamic models for the numerical simulation of intra-stent flows
Fatiha Chabi et al.
JOURNAL OF BIOMECHANICS (2015)
Thalamo-cortical network changes during the migraine cycle: insights from MRI-based microstructural and functional resting-state network correlation analysis
Gianluca Coppola et al.
JOURNAL OF HEADACHE AND PAIN (2015)
Migraine: Multiple Processes, Complex Pathophysiology
Rami Burstein et al.
JOURNAL OF NEUROSCIENCE (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Migraine pathophysiology: lessons from mouse models and human genetics
Michel D. Ferrari et al.
LANCET NEUROLOGY (2015)
Evidence for orexinergic mechanisms in migraine
Jan Hoffmann et al.
NEUROBIOLOGY OF DISEASE (2015)
Triptan-induced disruption of trigemino-cortical connectivity
Inga L. Kroeger et al.
NEUROLOGY (2015)
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
Eva Cernuda-Morollon et al.
PAIN (2015)
Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine
Simon Akerman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Adherence to oral migraine-preventive medications among patients with chronic migraine
Zsolt Hepp et al.
CEPHALALGIA (2015)
The thalamic reticular nucleus is activated by cortical spreading depression in freely moving rats: prevention by acute valproate administration
Nermin Tepe et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2015)
Pharmacological Trials in Migraine: It's Time to Reappraise Where the Headache Is and What the Pain Is Like
Piero Barbanti et al.
HEADACHE (2015)
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S. Walker et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Memantine for the Prevention of Primary Headache Disorders
Linda Huang et al.
ANNALS OF PHARMACOTHERAPY (2014)
Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks
Farooq Husain Maniyar et al.
BRAIN (2014)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
Marcelo E. Bigal et al.
CNS DRUGS (2014)
New Targets for Migraine Therapy
Amy R. Tso et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
An Exploratory Study of Salivary Calcitonin Gene-Related Peptide Levels Relative to Acute Interventions and Preventative Treatment With OnabotulinumtoxinA in Chronic Migraine
Roger Cady et al.
HEADACHE (2014)
CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
Eva Cernuda-Morollon et al.
HEADACHE (2014)
Calcitonin Gene-Related Peptide Receptor Antagonists: New Therapeutic Agents for Migraine
Ian M. Bell
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor
Inger Jansen-Olesen et al.
NEUROPEPTIDES (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
α-Calcitonin gene related peptide (α-CGRP) mediated lipid mobilization in 3T3-L1 adipocytes
Christopher S. Walker et al.
PEPTIDES (2014)
Altered Hypothalamic Functional Connectivity with Autonomic Circuits and the Locus Coeruleus in Migraine
Eric A. Moulton et al.
PLOS ONE (2014)
Neurochemical Pathways That Converge on Thalamic Trigeminovascular Neurons: Potential Substrate for Modulation of Migraine by Sleep, Food Intake, Stress and Anxiety
Rodrigo Noseda et al.
PLOS ONE (2014)
Pituitary adenylate cyclase activating polypeptide and migraine
Alessandro S. Zagami et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Migraine: a brain state
Andrew Charles
CURRENT OPINION IN NEUROLOGY (2013)
Why Does Sleep Stop Migraine?
Marcelo E. Bigal et al.
CURRENT PAIN AND HEADACHE REPORTS (2013)
Recent progress in migraine pathophysiology: role of cortical spreading depression and magnetic resonance imaging
Sonu Bhaskar et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
Marcelo E. Bigal et al.
HEADACHE (2013)
Preventive Pharmacologic Treatments for Episodic Migraine in Adults
Tatyana A. Shamliyan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2013)
Paraventricular Hypothalamic Regulation of Trigeminovascular Mechanisms Involved in Headaches
Claude Robert et al.
JOURNAL OF NEUROSCIENCE (2013)
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study
Faisal Mohammad Amin et al.
LANCET NEUROLOGY (2013)
HYPOTHALAMIC AND BASAL GANGLIA PROJECTIONS TO THE POSTERIOR THALAMUS: POSSIBLE ROLE IN MODULATION OF MIGRAINE HEADACHE AND PHOTOPHOBIA
R. Kagan et al.
NEUROSCIENCE (2013)
Bilateral Descending Hypothalamic Projections to the Spinal Trigeminal Nucleus Caudalis in Rats
Khaled Abdallah et al.
PLOS ONE (2013)
Role of kappa-opioid receptors in stress and anxiety-related behavior
Ashlee Van't Veer et al.
PSYCHOPHARMACOLOGY (2013)
Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura
Philip R. Holland et al.
ANNALS OF NEUROLOGY (2012)
A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization
Simon Akerman et al.
BRAIN (2012)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The enigma of the dorsolateral pons as a migraine generator
D. Borsook et al.
CEPHALALGIA (2012)
Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial
P. Hoever et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Migraine changes the brain: neuroimaging makes its mark
Till Sprenger et al.
CURRENT OPINION IN NEUROLOGY (2012)
Migraine: Maladaptive Brain Responses to Stress
Nasim Maleki et al.
HEADACHE (2012)
The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines
Elizabeth Loder et al.
HEADACHE (2012)
Postpartum Migraines: A Long-term Prospective Study
Eisei Hoshiyama et al.
INTERNAL MEDICINE (2012)
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial
Piero Barbanti et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Genome-wide association analysis identifies susceptibility loci for migraine without aura
Tobias Freilinger et al.
NATURE GENETICS (2012)
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Guy Griebel et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Orexin receptor antagonism for treatment of insomnia A randomized clinical trial of suvorexant
W. Joseph Herring et al.
NEUROLOGY (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
DISTRIBUTION OF VASOACTIVE INTESTINAL PEPTIDE, PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE, NITRIC OXIDE SYNTHASE, AND THEIR RECEPTORS IN HUMAN AND RAT SPHENOPALATINE GANGLION
A. Csati et al.
NEUROSCIENCE (2012)
Activation of Central Trigeminovascular Neurons by Cortical Spreading Depression
XiChun Zhang et al.
ANNALS OF NEUROLOGY (2011)
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
Kayi Y. Chan et al.
CEPHALALGIA (2011)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review
Michel Lanteri-Minet et al.
CEPHALALGIA (2011)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David J. Hewitt et al.
CEPHALALGIA (2011)
Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
Kathryn M. Connor et al.
HEADACHE (2011)
5-HT1D Receptor Immunoreactivity in the Sphenopalatine Ganglion: Implications for the Efficacy of Triptans in the Treatment of Autonomic Signs Associated With Cluster Headache
Jason J. Ivanusic et al.
HEADACHE (2011)
Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
Giorgio Sandrini et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Cortical Projections of Functionally Identified Thalamic Trigeminovascular Neurons: Implications for Migraine Headache and Its Associated Symptoms
Rodrigo Noseda et al.
JOURNAL OF NEUROSCIENCE (2011)
Trigeminal Nociceptive Transmission in Migraineurs Predicts Migraine Attacks
Anne Stankewitz et al.
JOURNAL OF NEUROSCIENCE (2011)
Diencephalic and brainstem mechanisms in migraine
Simon Akerman et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Thalamic Sensitization Transforms Localized Pain into Widespread Allodynia
Rami Burstein et al.
ANNALS OF NEUROLOGY (2010)
Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus
Oliver Summ et al.
BRAIN (2010)
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
M. R. Bruchas et al.
BRAIN RESEARCH (2010)
Trigger factors in migraine with aura
A. W. Hauge et al.
CEPHALALGIA (2010)
Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache
Hans Olav Hoivik et al.
CEPHALALGIA (2010)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
Ron J. Keizer et al.
CLINICAL PHARMACOKINETICS (2010)
TNF-alpha AND MICROGLIAL HORMETIC INVOLVEMENT IN NEUROLOGICAL HEALTH & MIGRAINE
Richard P. Kraig et al.
DOSE-RESPONSE (2010)
An Analysis of Migraine Triggers in a Clinic-Based Population
Diane Andress-Rothrock et al.
HEADACHE (2010)
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
D. C. Buse et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Changes of Meningeal Excitability Mediated by Corticotrigeminal Networks: A Link for the Endogenous Modulation of Migraine Pain
Rodrigo Noseda et al.
JOURNAL OF NEUROSCIENCE (2010)
Current practice and future directions in the prevention and acute management of migraine
Peter J. Goadsby et al.
LANCET NEUROLOGY (2010)
A neural mechanism for exacerbation of headache by light
Rodrigo Noseda et al.
NATURE NEUROSCIENCE (2010)
CGRP and its receptors provide new insights into migraine pathophysiology
Tony W. Ho et al.
NATURE REVIEWS NEUROLOGY (2010)
GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus
Anna P. Andreou et al.
NEUROBIOLOGY OF DISEASE (2010)
Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
F. Barkhof et al.
NEUROLOGY (2010)
DIFFERENTIAL DISTRIBUTION OF CALCITONIN GENE-RELATED PEPTIDE AND ITS RECEPTOR COMPONENTS IN THE HUMAN TRIGEMINAL GANGLION
S. Eftekhari et al.
NEUROSCIENCE (2010)
The PACAP Receptor: A Novel Target for Migraine Treatment
Henrik W. Schytz et al.
NEUROTHERAPEUTICS (2010)
Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development
Jane V. Aldrich et al.
AAPS JOURNAL (2009)
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)
Mark R. Hutchinson et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Therapeutic potential of novel glutamate receptor antagonists in migraine
Anna P. Andreou et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease
P. Rolan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Migraine in the Triptan Era: Lessons From Epidemiology, Pathophysiology, and Clinical Science
Marcelo E. Bigal et al.
HEADACHE (2009)
Expert Opinion: Adherence to Prophylactic Migraine Medication
Randolph W. Evans et al.
HEADACHE (2009)
Oxygen Inhibits Neuronal Activation in the Trigeminocervical Complex After Stimulation of Trigeminal Autonomic Reflex, But Not During Direct Dural Activation of Trigeminal Afferents
Simon Akerman et al.
HEADACHE (2009)
Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study
Annabelle R. Charbit et al.
JOURNAL OF NEUROSCIENCE (2009)
Immunotoxicity of monoclonal antibodies
Jacques Descotes
MABS (2009)
Pathological and protective roles of glia in chronic pain
Erin D. Milligan et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Could glial activation be a factor in migraine?
Jim Bartley
MEDICAL HYPOTHESES (2009)
Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses
Paul Rolan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Neuron-glia crosstalk gets serious: role in pain hypersensitivity
Ke Ren et al.
CURRENT OPINION IN ANESTHESIOLOGY (2008)
Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactlivity in the rat trigeminovascular system:: Differences between peripheral and central CGRP receptor distribution
Jochen K. Lennerz et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Acid sensing ion channels in dorsal spinal cord neurons
Anne Baron et al.
JOURNAL OF NEUROSCIENCE (2008)
The dysphoric component of stress is encoded by activation of the dynorphin κ-opioid system
Benjamin B. Land et al.
JOURNAL OF NEUROSCIENCE (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2008)
Pharmacological characterization of MK-0974 [N-[(3R, 6S)-6(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b] pyridin-1-yl)piperidine-1-carboxamide], a potent and orally Active calcitonin gene-related peptide receptor antagonist for the treatment of migraine
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system
Manuel A. Friese et al.
NATURE MEDICINE (2007)
Neuron-glia signaling in trigeminal ganglion: Implications for migraine pathology
Srikanth Thalakoti et al.
HEADACHE (2007)
The hypothalamic orexinergic system: Pain and primary headaches
Philip Holland et al.
HEADACHE (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Recent advances in understanding migraine mechanisms, molecules and therapeutics
Peter J. Goadsby
TRENDS IN MOLECULAR MEDICINE (2007)
Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A
Moshe Jakubowski et al.
PAIN (2006)
Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat
P. R. Holland et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Acid-sensing ion channels: advances, questions and therapeutic opportunities
John A. Wemmie et al.
TRENDS IN NEUROSCIENCES (2006)
The glial modulatory drug AV(411) attenuates mechanical allodynia in rat models of neuropathic pain
Annemarie Ledeboer et al.
NEURON GLIA BIOLOGY (2006)
Early development of therapeutic biologics - Pharmacokinetics
A Baumann
CURRENT DRUG METABOLISM (2006)
PACAP - A multifacetted neuropeptide
J Fahrenkrug
CHRONOBIOLOGY INTERNATIONAL (2006)
Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception
PR Holland et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The role of CGRP and nicotinic receptors in centrally evoked facial blood flow changes
S Just et al.
NEUROSCIENCE LETTERS (2005)
Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods
R Taffi et al.
CEPHALALGIA (2005)
BIBN4096BS antagonizes human α-calcitonin gene related peptide-induced headache and extracerebral artery dilatation
KA Petersen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia
T Mizuno et al.
NEUROPHARMACOLOGY (2004)
The premonitory symptoms (prodrome): A tertiary care study of 893 migraineurs
L Kelman
HEADACHE (2004)
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
RJ Storer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
M Iovino et al.
CEPHALALGIA (2004)
Vascular actions of calcitonin gene-related peptide and adrenomedullin
SD Brain et al.
PHYSIOLOGICAL REVIEWS (2004)
Hyperexcitability of the primary somatosensory cortex in migraine -: a magnetoencephalographic study
E Lang et al.
BRAIN (2004)
Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area
T Bartsch et al.
PAIN (2004)
Characterization of acid-sensing ion channels in dorsal horn neurons of rat spinal cord
LJ Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy
V Raghavendra et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Sumatriptan in migraine with unilateral cranial autonomic symptoms: An open study
P Barbanti et al.
HEADACHE (2003)
Premonitory symptoms in migraine - An electronic diary study
NJ Giffin et al.
NEUROLOGY (2003)
Migraine preventive medication reduces resource utilization
SD Silberstein et al.
HEADACHE (2003)
Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states
LR Watkins et al.
PHYSIOLOGICAL REVIEWS (2002)
Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input
T Bartsch et al.
BRAIN (2002)
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
DR Poyner et al.
PHARMACOLOGICAL REVIEWS (2002)
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model
H Bolay et al.
NATURE MEDICINE (2002)
Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors
D Levy et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2
R Uddman et al.
CEPHALALGIA (2002)
Glial activation: a driving force for pathological pain
LR Watkins et al.
TRENDS IN NEUROSCIENCES (2001)
Origin and co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat
L Edvinsson et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Mechanisms of migraine aura revealed by functional MRI in human visual cortex
N Hadjikhani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Brainstem activation specific to migraine headache
A Bahra et al.
LANCET (2001)
Deconstructing migraine headache into peripheral and central sensitization
R Burstein
PAIN (2001)
CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors
BN Evans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
CGRP and adrenomedullin binding correlates with transcript levels for Calcitonin Receptor-Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) in rat tissues
P Chakravarty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
